<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:09:11Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13903" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13903</identifier><datestamp>2026-10-18T21:13:28Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Benzenesulfonamide derivatives as potent acetylcholinesterase, α-glycosidase, and glutathione S-transferase inhibitors: biological evaluation and molecular docking studies</dc:title><dc:creator>Taslimi, Parham</dc:creator><dc:creator>Işık, Mesut</dc:creator><dc:creator>Türkan, Fikret</dc:creator><dc:creator>Durgun, Mustafa</dc:creator><dc:creator>Türkeş, Cüneyt</dc:creator><dc:creator>Gülçin, İlhami</dc:creator><dc:creator>Beydemir, Şükrü</dc:creator><dc:subject>acetylcholinesterase</dc:subject><dc:subject>glutathione S-transferase</dc:subject><dc:subject>molecular docking</dc:subject><dc:subject>sulfonamide derivatives</dc:subject><dc:subject>α-Glycosidase</dc:subject><dc:subject>Cholinesterase Inhibitors</dc:subject><dc:subject>Glutathione Transferase</dc:subject><dc:subject>Glycoside Hydrolases</dc:subject><dc:subject>Molecular Docking Simulation</dc:subject><dc:subject>Structure-Activity Relationship</dc:subject><dc:subject>Sulfonamides</dc:subject><dc:subject>alpha glycosidase</dc:subject><dc:subject>benzenesulfonamide derivative</dc:subject><dc:subject>glycosidase</dc:subject><dc:subject>methanol</dc:subject><dc:subject>sodium borohydride</dc:subject><dc:subject>unclassified drug</dc:subject><dc:subject>benzenesulfonamide</dc:subject><dc:subject>cholinesterase inhibitor</dc:subject><dc:subject>sulfonamide</dc:subject><dc:subject>Article</dc:subject><dc:subject>concentration response</dc:subject><dc:subject>crystal structure</dc:subject><dc:subject>drug activity</dc:subject><dc:subject>drug binding</dc:subject><dc:subject>drug structure</dc:subject><dc:subject>enzyme inhibition</dc:subject><dc:subject>priority journal</dc:subject><dc:subject>receptor binding</dc:subject><dc:subject>structure activity relation</dc:subject><dc:description>Sulfonamide derivatives exhibit a wide biological activity and can function as potential medical molecules in the development of a drug. Studies have reported that the compounds have an effect on many enzymes. In this study, the derivatives of amine sulfonamide (1i-11i) were prepared with reduced imine compounds (1-11) with NaBH4 in methanol. The synthesized compounds were fully characterized by spectral data and analytical. The effect of the synthesized derivatives on acetylcholinesterase (AChE), glutathione S-transferase (GST) and α-glycosidase (α-GLY) enzymes were determined. For the AChE and α-GLY, the most powerful inhibition was observed on 10 and 10i series with K I value in the range 2.26 ± 0.45–3.57 ± 0.97 and 95.73 ± 13.67–102.45 ± 11.72 µM, respectively. K I values of the series for GST were found in the range of 22.76 ± 1.23–49.29 ± 4.49. Finally, the compounds have a stronger inhibitor in lower concentrations by the attachment of functional electronegative groups such as two halogens (-Br and -CI), -OH to the benzene ring and -SO2NH2. The crystal structures of AChE, α-GLY, and GST in complex with selected derivatives 4 and 10 show the importance of the functional moieties in the binding modes within the receptors. Communicated by Ramaswamy H. Sarma. © 2020, © 2020 Informa UK Limited, trading as Taylor &amp; Francis Group.</dc:description><dc:publisher>Taylor and Francis Ltd.</dc:publisher><dc:date>2020</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/13903</dc:identifier><dc:identifier>https://doi.org/10.1080/07391102.2020.1790422</dc:identifier><dc:identifier>0739-1102</dc:identifier><dc:language>en</dc:language><dc:relation>Journal of Biomolecular Structure and Dynamics</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/13903</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>